Skip to main content
Top
Published in: Journal of Neurology 3/2019

01-03-2019 | Original Communication

Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review

Authors: Ari Breiner, David Moher, John Brooks, Wei Cheng, Harald Hegen, Florian Deisenhammer, Christopher R. McCudden, Pierre R. Bourque

Published in: Journal of Neurology | Issue 3/2019

Login to get access

Abstract

Background

Cerebrospinal fluid total protein (CSF-TP) is measured in the diagnosis of a range of immune or infectious disorders of the nervous system. Most laboratories and the medical literature use an antiquated, age-independent upper limit of 0.45 g/L. Therefore, we performed a systematic review of reference studies in the medical literature, with the primary objective of determining the CSF total protein upper reference limit (URL). Secondary objectives were to assess the effects of age, gender, laboratory methods, and methodological quality.

Methods

A pre-planned and peer-reviewed electronic search strategy was used to search Ovid Medline and EMBASE for 1960–2017. All records underwent title/abstract review, and potentially relevant records underwent independent full-text review by two researchers. The remaining studies underwent quality assessment using a modification of the QUADAS2 revised tool. CSF-TP upper reference limits extracted from these studies were used to compute weighted means.

Results

Twenty-two articles were retained for qualitative analysis and 20 for quantitative analysis. The weighted average of CSF-TP URL was 0.55 g/L, in studies with high methodological quality. Studies that examined the effect of age reported consistent correlations with advancing age, and CSF-TP URL values incrementally exceeded 0.60 g/L after age 50. There were no meaningful differences according to gender, laboratory method, or quality assessment score.

Conclusions

There is concordance in available literature to recommend increasing CSF total protein upper reference limits, and to consider implementing age-adjusted values above 0.60 g/L starting at age 50. This information merits worldwide dissemination, to reduce the risk of over-diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Merritt Houston, H F-SF (1937) The cerebrospinal fluid. W.B. Saunders, Philadelphia Merritt Houston, H F-SF (1937) The cerebrospinal fluid. W.B. Saunders, Philadelphia
2.
go back to reference Daroff RB, Bradley WG, Jankovic J, Mazziotta JC, Pomeroy SL, Elsevier (2016) Bradley’s neurology in clinical practice, vol 2. Elsevier, London [etc.] Daroff RB, Bradley WG, Jankovic J, Mazziotta JC, Pomeroy SL, Elsevier (2016) Bradley’s neurology in clinical practice, vol 2. Elsevier, London [etc.]
3.
go back to reference Goldman L, Schafer AI (2016) Goldman-cecil medicine, 25th edn. Elsevier/Saunders, Philadelphia, PA, USA Goldman L, Schafer AI (2016) Goldman-cecil medicine, 25th edn. Elsevier/Saunders, Philadelphia, PA, USA
4.
go back to reference Hegen H, Auer M, Zeileis A, Deisenhammer F (2016) Upper reference limits for cerebrospinal fluid total protein and albumin quotient based on a large cohort of control patients: implications for increased clinical specificity. Clin Chem Lab Med 54:285–292CrossRefPubMed Hegen H, Auer M, Zeileis A, Deisenhammer F (2016) Upper reference limits for cerebrospinal fluid total protein and albumin quotient based on a large cohort of control patients: implications for increased clinical specificity. Clin Chem Lab Med 54:285–292CrossRefPubMed
5.
go back to reference McCudden CR, Brooks J, Figurado P, Bourque PR (2017) Cerebrospinal fluid total protein reference intervals derived from 20 years of patient data. Clin Chem 63(12):1856–1865CrossRefPubMed McCudden CR, Brooks J, Figurado P, Bourque PR (2017) Cerebrospinal fluid total protein reference intervals derived from 20 years of patient data. Clin Chem 63(12):1856–1865CrossRefPubMed
6.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100CrossRefPubMedCentralPubMed Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100CrossRefPubMedCentralPubMed
7.
go back to reference McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C (2016) PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol 75:40–46CrossRefPubMed McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C (2016) PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol 75:40–46CrossRefPubMed
8.
go back to reference Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536CrossRefPubMed Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536CrossRefPubMed
10.
go back to reference Lott JA, Warren P (1989) Estimation of reference intervals for total protein in cerebrospinal fluid. Clin Chem 35:1766–1770PubMed Lott JA, Warren P (1989) Estimation of reference intervals for total protein in cerebrospinal fluid. Clin Chem 35:1766–1770PubMed
11.
go back to reference Ben Menachem E, Persson L, Schechter PJ, Haegele KD, Huebert N, Hardenberg J (1989) Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures. J Neurochem 52:632–635CrossRefPubMed Ben Menachem E, Persson L, Schechter PJ, Haegele KD, Huebert N, Hardenberg J (1989) Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures. J Neurochem 52:632–635CrossRefPubMed
12.
go back to reference Hirohata S, Inoue T, Yamada A, Hirose S, Miyamoto T (1984) Quantitation of IgG, IgA and IgM in the cerebrospinal fluid by a solid-phase enzyme-immunoassay. Establishment of normal control values. J Neurol Sci 63:101–110CrossRefPubMed Hirohata S, Inoue T, Yamada A, Hirose S, Miyamoto T (1984) Quantitation of IgG, IgA and IgM in the cerebrospinal fluid by a solid-phase enzyme-immunoassay. Establishment of normal control values. J Neurol Sci 63:101–110CrossRefPubMed
13.
go back to reference Merril CR, Harrington MG (1984) ‘Ultrasensitive’ silver stains: their use exemplified in the study of normal human cerebrospinal fluid proteins separated by two-dimensional electrophoresis. Clin Chem 30:1938–1942PubMed Merril CR, Harrington MG (1984) ‘Ultrasensitive’ silver stains: their use exemplified in the study of normal human cerebrospinal fluid proteins separated by two-dimensional electrophoresis. Clin Chem 30:1938–1942PubMed
14.
go back to reference Wikkelso C, Blomstrand C, Ronnback L (1981) Cerebrospinal fluid specific proteins in multiinfarct and senile dementia. J Neurol Sci 49:293–303CrossRefPubMed Wikkelso C, Blomstrand C, Ronnback L (1981) Cerebrospinal fluid specific proteins in multiinfarct and senile dementia. J Neurol Sci 49:293–303CrossRefPubMed
15.
go back to reference Eeg-Olofsson O, Link H, Wigertz A (1981) Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CNS in ‘normal’ subjects from the age of 6 months to 30 years. Acta Paediatr Scand 70:167–170CrossRefPubMed Eeg-Olofsson O, Link H, Wigertz A (1981) Concentrations of CSF proteins as a measure of blood brain barrier function and synthesis of IgG within the CNS in ‘normal’ subjects from the age of 6 months to 30 years. Acta Paediatr Scand 70:167–170CrossRefPubMed
16.
go back to reference Ahonen A, Myllyla VV, Hokkanen E (1978) Measurement of reference values for certain proteins in cerebrospinal fluid. Acta Neurol Scand 58:358–365CrossRefPubMed Ahonen A, Myllyla VV, Hokkanen E (1978) Measurement of reference values for certain proteins in cerebrospinal fluid. Acta Neurol Scand 58:358–365CrossRefPubMed
17.
go back to reference Bernhardt W, Weisner B, Rehpenning W (1978) Laboratory findings in cerebrospinal fluid in relation to age: trivariate evaluation of albumin and immunoglobulin G concentrations. J Clin Chem Clin Biochem 16:435–439 (author’s transl) PubMed Bernhardt W, Weisner B, Rehpenning W (1978) Laboratory findings in cerebrospinal fluid in relation to age: trivariate evaluation of albumin and immunoglobulin G concentrations. J Clin Chem Clin Biochem 16:435–439 (author’s transl) PubMed
18.
go back to reference Stibler H (1978) The normal cerebrospinal fluid proteins identified by means of thin-layer isoelectric focusing and crossed immunoelectrofocusing. J Neurol Sci 36:273–288CrossRefPubMed Stibler H (1978) The normal cerebrospinal fluid proteins identified by means of thin-layer isoelectric focusing and crossed immunoelectrofocusing. J Neurol Sci 36:273–288CrossRefPubMed
19.
go back to reference Thomsen J, Bech P, Nielsen OS (1978) CSF total protein: normal values. A re-appraisal and discussion of its value in diagnosis of acoustic neuromas. Acta Oto-Laryngol 86:359–365 Thomsen J, Bech P, Nielsen OS (1978) CSF total protein: normal values. A re-appraisal and discussion of its value in diagnosis of acoustic neuromas. Acta Oto-Laryngol 86:359–365
20.
go back to reference Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Investig 37:385–390CrossRef Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Investig 37:385–390CrossRef
21.
go back to reference Takeoka T, Gotoh F, Furumi K, Mori K (1976) Polyacrylamide-gel disc electrophoresis of native cerebrospinal fluid proteins with special reference to immunoglobulins and some clinical applications. J Neurol Sci 29:213–239CrossRefPubMed Takeoka T, Gotoh F, Furumi K, Mori K (1976) Polyacrylamide-gel disc electrophoresis of native cerebrospinal fluid proteins with special reference to immunoglobulins and some clinical applications. J Neurol Sci 29:213–239CrossRefPubMed
22.
go back to reference Jung PR, Rieder HP, Jeltsch C (1973) Total protein levels in lumbar cerebrospinal fluid of normal subjects. Klinische Wochenschrift 51:810–816CrossRefPubMed Jung PR, Rieder HP, Jeltsch C (1973) Total protein levels in lumbar cerebrospinal fluid of normal subjects. Klinische Wochenschrift 51:810–816CrossRefPubMed
23.
go back to reference Mertin J, Wisser H, Doerr P (1971) Studies on the normal concentration range of total protein and the total protein fractions of the cerebrospinal fluid by electrophoresis on cellulose acetate. Zeitschrift fur klinische Chemie klinische Biochemie 9:337–340 (author’s transl) Mertin J, Wisser H, Doerr P (1971) Studies on the normal concentration range of total protein and the total protein fractions of the cerebrospinal fluid by electrophoresis on cellulose acetate. Zeitschrift fur klinische Chemie klinische Biochemie 9:337–340 (author’s transl)
24.
go back to reference Igou PC (1967) Normal values for cellulose acetate electrophoresis of spinal fluid proteins. Amer J Med Technol 33:501–504 Igou PC (1967) Normal values for cellulose acetate electrophoresis of spinal fluid proteins. Amer J Med Technol 33:501–504
25.
go back to reference Gilland O (1967) Lumbar cerebrospinal fluid total protein in healthy subjects. Acta Neurol Scand 43:526–529CrossRefPubMed Gilland O (1967) Lumbar cerebrospinal fluid total protein in healthy subjects. Acta Neurol Scand 43:526–529CrossRefPubMed
26.
go back to reference Arnold F (1966) Cerebrosplnal liquid examinations in healthy individuals and in patients with multiple sclerosis. Schweizerische Medizinische Wochenschrift 96:1098–1103PubMed Arnold F (1966) Cerebrosplnal liquid examinations in healthy individuals and in patients with multiple sclerosis. Schweizerische Medizinische Wochenschrift 96:1098–1103PubMed
28.
go back to reference Rieder HP, Wuthrich R (1962) The cu-folin method for determining the total proteinsin the csf. KljnWschr 40:241–255 Rieder HP, Wuthrich R (1962) The cu-folin method for determining the total proteinsin the csf. KljnWschr 40:241–255
29.
go back to reference Ahonen A, Myllyla VV, Hokkanen E (1979) Cerebrospinal fluid protein findings in various lower back pain syndromes. Acta Neurol Scand 60:93–99CrossRefPubMed Ahonen A, Myllyla VV, Hokkanen E (1979) Cerebrospinal fluid protein findings in various lower back pain syndromes. Acta Neurol Scand 60:93–99CrossRefPubMed
30.
go back to reference Breebaart K, Becker H, Jongebloed FA (1978) Investigation of reference values of components of cerebrospinal fluid. J Clin Chem Clin Biochem 16:561–565PubMed Breebaart K, Becker H, Jongebloed FA (1978) Investigation of reference values of components of cerebrospinal fluid. J Clin Chem Clin Biochem 16:561–565PubMed
31.
go back to reference Teunissen C, Menge T, Altintas A, Alvarez-Cermeno JC, Bertolotto A, Berven FS, Brundin L, Comabella M, Degn M, Deisenhammer F, Fazekas F, Franciotta D, Frederiksen JL, Galimberti D, Gnanapavan S, Hegen H, Hemmer B, Hintzen R, Hughes S, Iacobaeus E, Kroksveen AC, Kuhle J, Richert J, Tumani H, Villar LM, Drulovic J, Dujmovic I, Khalil M, Bartos A (2013) Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 19:1802–1809CrossRefPubMed Teunissen C, Menge T, Altintas A, Alvarez-Cermeno JC, Bertolotto A, Berven FS, Brundin L, Comabella M, Degn M, Deisenhammer F, Fazekas F, Franciotta D, Frederiksen JL, Galimberti D, Gnanapavan S, Hegen H, Hemmer B, Hintzen R, Hughes S, Iacobaeus E, Kroksveen AC, Kuhle J, Richert J, Tumani H, Villar LM, Drulovic J, Dujmovic I, Khalil M, Bartos A (2013) Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 19:1802–1809CrossRefPubMed
32.
go back to reference Dufour-Rainfray D, Beaufils E, Vourc’h P, Vierron E, Mereghetti L, Gendrot C, Hommet C, Andres CR, Guilloteau D, Mondon K (2013) Total protein level in cerebrospinal fluid is stable in elderly adults. J Am Geriatr Soc 61:1819–1821CrossRefPubMed Dufour-Rainfray D, Beaufils E, Vourc’h P, Vierron E, Mereghetti L, Gendrot C, Hommet C, Andres CR, Guilloteau D, Mondon K (2013) Total protein level in cerebrospinal fluid is stable in elderly adults. J Am Geriatr Soc 61:1819–1821CrossRefPubMed
33.
go back to reference Kleine TO, Weber L, Zofel P (1988) Changes with age in leucocyte counts, protein and IgG content of lumbar cerebrospinal fluid (CSF) of patients with inflammatory, ischemic, and hemorrhagic diseases or tumors of the central nervous system (CNS). Zeitschrift fur Gerontologie 21:102–105PubMed Kleine TO, Weber L, Zofel P (1988) Changes with age in leucocyte counts, protein and IgG content of lumbar cerebrospinal fluid (CSF) of patients with inflammatory, ischemic, and hemorrhagic diseases or tumors of the central nervous system (CNS). Zeitschrift fur Gerontologie 21:102–105PubMed
34.
go back to reference Seyfert S, Kunzmann V, Schwertfeger N, Koch HC, Faulstich A (2002) Determinants of lumbar CSF protein concentration. J Neurol 249:1021–1026CrossRefPubMed Seyfert S, Kunzmann V, Schwertfeger N, Koch HC, Faulstich A (2002) Determinants of lumbar CSF protein concentration. J Neurol 249:1021–1026CrossRefPubMed
35.
go back to reference Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelso C (1993) Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18–88 years of age. Eur Neurol 33:129–133CrossRefPubMed Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelso C (1993) Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18–88 years of age. Eur Neurol 33:129–133CrossRefPubMed
36.
go back to reference Allen JA, Lewis RA (2015) CIDP diagnostic pitfalls and perception of treatment benefit. Neurology 85:498–504CrossRefPubMed Allen JA, Lewis RA (2015) CIDP diagnostic pitfalls and perception of treatment benefit. Neurology 85:498–504CrossRefPubMed
37.
go back to reference Datar S, Singh TD, Fugate JE, Mandrekar J, Rabinstein AA, Hocker S (2015) Albuminocytologic dissociation in posterior reversible encephalopathy syndrome. Mayo Clin Proc 90:1366–1371CrossRefPubMed Datar S, Singh TD, Fugate JE, Mandrekar J, Rabinstein AA, Hocker S (2015) Albuminocytologic dissociation in posterior reversible encephalopathy syndrome. Mayo Clin Proc 90:1366–1371CrossRefPubMed
38.
go back to reference Jarius S, Hoffmann L, Clover L, Vincent A, Voltz R (2008) CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 268:74–77CrossRefPubMed Jarius S, Hoffmann L, Clover L, Vincent A, Voltz R (2008) CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 268:74–77CrossRefPubMed
39.
go back to reference Lott JA, Mitchell LC, Moeschberger ML, Sutherland DE (1992) Estimation of reference ranges: how many subjects are needed? Clin Chem 38:648–650PubMed Lott JA, Mitchell LC, Moeschberger ML, Sutherland DE (1992) Estimation of reference ranges: how many subjects are needed? Clin Chem 38:648–650PubMed
40.
go back to reference Shah SS, Ebberson J, Kestenbaum LA, Hodinka RL, Zorc JJ (2011) Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants. J Hosp Med 6:22–27CrossRefPubMed Shah SS, Ebberson J, Kestenbaum LA, Hodinka RL, Zorc JJ (2011) Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants. J Hosp Med 6:22–27CrossRefPubMed
Metadata
Title
Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review
Authors
Ari Breiner
David Moher
John Brooks
Wei Cheng
Harald Hegen
Florian Deisenhammer
Christopher R. McCudden
Pierre R. Bourque
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 3/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-09174-z

Other articles of this Issue 3/2019

Journal of Neurology 3/2019 Go to the issue